7 research outputs found

    In vitro anti-viral activity of aqueous extracts of Kenyan Carissa edulis Prunus africana and Melia azedarach against human cytomegalovirus.

    Get PDF
    The aqueous extracts of three medicinal plants, Carissa edulis (Forssk.) Vahl (Apocynaceae), Prunus africana (Hook.f.) Kalkm (Rosaceae) and Melia azedarach L. (Meliaceae) have shown significant reduction in the replication of human cytomegalovirus (HCMV) in human embryonic lung (HEL) fibroblasts cells in vitro. Using the plaque inhibition assay for the determination of anti-viral activity, the HEL fibroblast cells cultured in 24 well plates were infected with 1 x 102 PFU 91S HCMV and treated with various concentrations of the extracts. The plaques formed were counted after 7 days incubation at 370C in 5% CO2 and the percent plaques inhibited were calculated against infected untreated control. The effective concentrations inhibiting plaque formation by 50% (EC50) was found between 40 to 80 μg/ml for all the extracts. The cell cytotoxic concentrations (CC50) for each of the three extracts, by the trypan blue exclusion test, gave a safe therapeutic index. These results have demonstrated the potential anti-viral activities of the extracts of the three medicinal plants at non-cytotoxic concentrations. African Journal of Health Sciences Vol. 14 (3-4) 2007: pp. 143-14

    Rare causes of scoliosis and spine deformity: experience and particular features

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Spine deformity can be idiopathic (more than 80% of cases), neuromuscular, congenital or neurofibromatosis-related. However, there are many disorders that may also be involved. We present our experience treating patients with scoliosis or other spine deformities related to rare clinical entities.</p> <p>Methods</p> <p>A retrospective study of the records of a school-screening study in North-West Greece was performed, covering a 10-year period (1992–2002). The records were searched for patients with deformities related to rare disorders. These patients were reviewed as regards to characteristics of underlying disorder and spine deformity, treatment and results, complications, intraoperative and anaesthesiologic difficulties particular to each case.</p> <p>Results</p> <p>In 13 cases, the spine deformity presented in relation to rare disorders. The underlying disorder was rare neurological disease in 2 cases (Rett syndrome, progressive hemidystonia), muscular disorders (facioscapulohumeral muscular dystrophy, arthrogryposis) in 2 patients, osteogenesis imperfecta in 2 cases, Marfan syndrome, osteopetrosis tarda, spondyloepiphyseal dysplasia congenita, cleidocranial dysplasia and Noonan syndrome in 1 case each. In 2 cases scoliosis was related to other congenital anomalies (phocomelia, blindness). Nine of these patients were surgically treated. Surgery was avoided in 3 patients.</p> <p>Conclusion</p> <p>This study illustrates the fact that different disorders are related with curves with different characteristics, different accompanying problems and possible complications. Investigation and understanding of the underlying pathology is an essential part of the clinical evaluation and preoperative work-up, as clinical experience at any specific center is limited.</p

    SOSORT consensus paper: school screening for scoliosis. Where are we today?

    Get PDF
    This report is the SOSORT Consensus Paper on School Screening for Scoliosis discussed at the 4th International Conference on Conservative Management of Spinal Deformities, presented by SOSORT, on May 2007. The objectives were numerous, 1) the inclusion of the existing information on the issue, 2) the analysis and discussion of the responses by the meeting attendees to the twenty six questions of the questionnaire, 3) the impact of screening on frequency of surgical treatment and of its discontinuation, 4) the reasons why these programs must be continued, 5) the evolving aim of School Screening for Scoliosis and 6) recommendations for improvement of the procedure

    The anti-viral effect of Acacia mellifera, Melia azedarach and Prunus Africana, extracts against herpes simplex virus type 1 infection in mice

    No full text
    Aqueous extracts from the stem barks of Prunus africana(Hook.f.) Kalkm, Acacia mellifera (Vahl.) Benth. and Melia azedarach L. were evaluated for in vivo antiviral activity in Balb/C mice following a cutaneous wild type strain 7401H herpes simplex virus type 1 (HSV-1) infection. A significant therapeutic effect was observed when the infected mice were orally treated with the extracts of Prunus africana and Acacia mellifera at a dose of 500 mg/kg. A delayed onset of skin lesions, slowed progression of infection and a prolonged mean survival time was expressed as opposed to the untreated infected control (p &#8804;0.05). Treatment with the Melia azedarach extract at a dose of 500 mg/kg was acutely toxic to mice, however a reasonable antiviral activity was exhibited at a lower dose of 250 mg/kg. No acute toxicity was presented in mice treated withP. africana and A. mellifera at the therapeutic dose. The results suggest the presence of anti-HSV agents in these medicinal plant extracts that can be exploited as possible antivirals. Keywords: Prunus africana, Acacia mellifera, Melia azedarach, HSV-1, antiviral activity, medicinal plants Journal of Tropical Microbiology and Biotechnology Vol. 2(1) 2006: 3-

    Analysis of host responses and risk for disease progression

    No full text
    corecore